Cargando…
Suppression of the generation of lymphokine-activated killer (LAK) cells by serum-free supernatants of in vitro maintained tumour cell lines.
Serum-free supernatants from in vitro maintained gastrointestinal cancer and melanoma cell lines inhibit the generation of lymphokine (IL-2) activated killer (LAK) cells in a time and dose-related manner. Concentrations as low as 5% can inhibit the generation of LAK cytotoxicity but inhibition of pr...
Autores principales: | Guillou, P. J., Ramsden, C. W., Somers, S. S., Sedman, P. C. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1989
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2247131/ https://www.ncbi.nlm.nih.gov/pubmed/2785396 |
Ejemplares similares
-
Paradoxical effects of 5-FU/folinic acid on lymphokine-activated killer (LAK) cell induction in patients with colorectal cancer.
por: Onodera, H., et al.
Publicado: (1990) -
Generation of adherent lymphokine activated killer (A-LAK) cells from patients with acute myelogenous leukaemia.
por: Sedlmayr, P., et al.
Publicado: (1992) -
Studies of lymphokine-activated killer (LAK) cells. I. Evidence using novel monoclonal antibodies that most human LAK precursor cells share a common surface marker
Publicado: (1989) -
Natural killer and lymphokine activated killer cell functions in Hodgkin's disease.
por: Rajaram, N., et al.
Publicado: (1990) -
Efficacy of chemoimmunotherapy with cyclophosphamide, interleukin-2 and lymphokine activated killer cells in an intraperitoneal murine tumour model.
por: Eggermont, A. M., et al.
Publicado: (1988)